CannAssist International (CNSC) Corporate Media Kit

The concept and development of CBD therapies with better results 2015 CiBiDinol Research trials begin 2016 Initiated consumer product testing Contracted national distributor for raw material, CiBiDinol for cosmetic and personal care industry 2019 MILESTONES Third-party testing results confirm superior bioavailability performance Xceptol brand development Applied for Public Company Status Proof of concept trials Consumer product formulation development Registration of CannAssist International 2017 2018 Continued Growth CNSC registered with OTCQB Public Market Xceptol Brand Launch Pain Cream Managing Director Sales and Marketing REG-A Tier 2 approval Partner with InvesterBrandNetwork Xceptol Brand Launches Capsules and Drops 2020